KyungMann Kim

14PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 10, 2026
Phase 1b breast cancer prevention clinical trial of 9cUAB30 administered prior to surgical resection.

|Oct 06, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer.

Britt K Erickson, Howard Bailey, Rebecca C Arend

|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.

Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski

|Sep 18, 2024
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.

Justin C Jagodinsky, Jessica M Vera, Won Jong Jin

|Aug 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery.

Tracy M Downs, Howard H Bailey, Taja Lozar

|May 31, 2023
A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials.

Jens Eickhoff, Jen Zaborek, Guanhua Chen

Pageof 3

Frequent Collaborators

3 joint publications

Jen Zaborek

3 joint publications

Lisa Barroilhet

3 joint publications

Katina DeShong

3 joint publications

Thomas Havighurst